Immunological Monitoring for Guidance of Preemptive Antiviral Therapy for Active Cytomegalovirus Infection in Allogeneic Stem-Cell Transplant Recipients: A Pilot Experience

This publication has 11 references indexed in Scilit:

• Kinetics of cytomegalovirus (CMV) pp65 and IE‐1‐specific IFNγ CD8⁺ and CD4⁺ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: Potential implications for the management of active CMV infection
  Journal of Medical Virology, 2010
• Clinical Virology of Cytomegalovirus Infection Following Hematopoietic Transplantation
  Future Virology, 2009
• Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients
  Bone Marrow Transplantation, 2009
• Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients
  Journal of Clinical Microbiology, 2008
• Enumeration of cytomegalovirus-specific interferon CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection
  Haematologica, 2008
• Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
  Bone Marrow Transplantation, 2008
• Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection
  Haematologica, 2008
• Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT
  Bone Marrow Transplantation, 2007
• Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients
  Journal of Clinical Virology, 2006
• Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
  Blood, 2003